Anti-HSV1 gE Envelope Protein 抗体 [9H3] (ab6510)
Key features and details
- Mouse monoclonal [9H3] to HSV1 gE Envelope Protein
- Suitable for: ELISA, ICC/IF, WB
- Isotype: IgG2a
製品の概要
-
製品名
Anti-HSV1 gE Envelope Protein antibody [9H3] -
製品の詳細
Mouse monoclonal [9H3] to HSV1 gE Envelope Protein -
由来種
Mouse -
アプリケーション
適用あり: ELISA, ICC/IF, WBmore details -
種交差性
交差種: Other species -
免疫原
Tissue, cells or virus corresponding to HSV1 gE Envelope Protein.
-
特記事項
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles. -
バッファー
pH: 7.4 -
Concentration information loading... -
精製度
Protein A purified -
ポリ/モノ
モノクローナル -
クローン名
9H3 -
ミエローマ
NS1/1-Ag4-1 -
アイソタイプ
IgG2a -
軽鎖の種類
kappa -
研究分野
関連製品
-
Compatible Secondaries
-
Isotype control
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab6510の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
| アプリケーション | Abreviews | 特記事項 |
|---|---|---|
| ELISA |
Use at an assay dependent concentration.
0.100 @ >1:102,400 |
|
| ICC/IF |
1/6400.
1+ @ 1:6,400 |
|
| WB |
Use at an assay dependent concentration. PubMed: 16571817
|
| 特記事項 |
|---|
|
ELISA
Use at an assay dependent concentration. 0.100 @ >1:102,400 |
|
ICC/IF
1/6400. 1+ @ 1:6,400 |
|
WB
Use at an assay dependent concentration. PubMed: 16571817 |
ターゲット情報
-
関連性
There are 2 antigenic types of Herpes Simplex Virus, HSV1 and HSV2 which share antigenic cross reactivity but different neutralization patterns and tend to produce different clinical symptoms. Humans are believed to be the natural host for HSV, but the virus is also capable of infecting various animals, including rodents. -
別名
- Envelope glycoprotein E antibody
- GE antibody
- Glycoprotein E antibody
see all
プロトコール
データシートおよび資料
-
SDS download
-
Datasheet download
参考文献 (8)
ab6510 は 8 報の論文で使用されています。
- Denes CE et al. A putative WAVE regulatory complex (WRC) interacting receptor sequence (WIRS) in the cytoplasmic tail of HSV-1 gE does not function in WRC recruitment or neuronal transport. Access Microbiol 3:000206 (2021). PubMed: 34151161
- Qiao H et al. Herpes simplex virus type 1 infection leads to neurodevelopmental disorder-associated neuropathological changes. PLoS Pathog 16:e1008899 (2020). PubMed: 33091073
- Zhang W et al. Induction of Rod-Shaped Structures by Herpes Simplex Virus Glycoprotein I. J Virol 94:N/A (2020). PubMed: 32581097
- Dai HS et al. The Fc Domain of Immunoglobulin Is Sufficient to Bridge NK Cells with Virally Infected Cells. Immunity 47:159-170.e10 (2017). PubMed: 28723548
- Oda S et al. The Interaction between Herpes Simplex Virus 1 Tegument Proteins UL51 and UL14 and Its Role in Virion Morphogenesis. J Virol 90:8754-67 (2016). PubMed: 27440890
- Arii J et al. Nonmuscle myosin heavy chain IIb mediates herpes simplex virus 1 entry. J Virol 89:1879-88 (2015). PubMed: 25428876
- Maringer K et al. A network of protein interactions around the herpes simplex virus tegument protein VP22. J Virol 86:12971-82 (2012). IP . PubMed: 22993164
- Orlando JS et al. The products of the herpes simplex virus type 1 immediate-early US1/US1.5 genes downregulate levels of S-phase-specific cyclins and facilitate virus replication in S-phase Vero cells. J Virol 80:4005-16 (2006). WB . PubMed: 16571817